Teacher Retirement System of Texas Trims Stock Position in Agilent Technologies, Inc. $A

Teacher Retirement System of Texas cut its holdings in Agilent Technologies, Inc. (NYSE:A) by 30.7% during the 3rd quarter, Holdings Channel reports. The firm owned 104,934 shares of the medical research company’s stock after selling 46,563 shares during the period. Teacher Retirement System of Texas’ holdings in Agilent Technologies were worth $13,468,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of A. Norges Bank acquired a new stake in Agilent Technologies during the 2nd quarter valued at $395,088,000. AQR Capital Management LLC lifted its position in shares of Agilent Technologies by 424.1% in the second quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock valued at $240,956,000 after acquiring an additional 1,652,244 shares in the last quarter. Ameriprise Financial Inc. boosted its stake in shares of Agilent Technologies by 132.2% during the second quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock valued at $277,807,000 after acquiring an additional 1,340,161 shares during the last quarter. Massachusetts Financial Services Co. MA increased its position in Agilent Technologies by 10.7% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 13,227,387 shares of the medical research company’s stock worth $1,560,964,000 after purchasing an additional 1,273,994 shares in the last quarter. Finally, Troy Asset Management Ltd raised its stake in Agilent Technologies by 74.3% in the 2nd quarter. Troy Asset Management Ltd now owns 2,397,820 shares of the medical research company’s stock valued at $282,967,000 after purchasing an additional 1,021,865 shares during the last quarter. 87.41% of the stock is currently owned by institutional investors and hedge funds.

Agilent Technologies Stock Down 2.7%

Shares of A opened at $134.90 on Friday. The firm has a market cap of $38.24 billion, a PE ratio of 29.52, a price-to-earnings-growth ratio of 3.92 and a beta of 1.29. The company’s fifty day moving average is $143.36 and its two-hundred day moving average is $134.05. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $160.27. The company has a quick ratio of 1.52, a current ratio of 1.96 and a debt-to-equity ratio of 0.45.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Monday, November 24th. The medical research company reported $1.59 EPS for the quarter, topping analysts’ consensus estimates of $1.58 by $0.01. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The business had revenue of $1.86 billion during the quarter, compared to the consensus estimate of $1.83 billion. During the same period in the prior year, the firm posted $1.46 EPS. The business’s revenue for the quarter was up 9.4% on a year-over-year basis. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th will be paid a $0.255 dividend. The ex-dividend date of this dividend is Tuesday, January 6th. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.25. Agilent Technologies’s dividend payout ratio is presently 22.32%.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, VP Rodney Gonsalves sold 3,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total transaction of $464,970.00. Following the completion of the sale, the vice president directly owned 31,846 shares in the company, valued at $4,935,811.54. The trade was a 8.61% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Padraig Mcdonnell sold 911 shares of the stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $143.24, for a total transaction of $130,491.64. Following the completion of the sale, the chief executive officer directly owned 32,058 shares of the company’s stock, valued at $4,591,987.92. The trade was a 2.76% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 16,401 shares of company stock valued at $2,468,962 in the last quarter. Company insiders own 0.26% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on the stock. UBS Group lifted their price target on shares of Agilent Technologies from $170.00 to $180.00 and gave the stock a “buy” rating in a report on Tuesday, November 25th. Barclays raised shares of Agilent Technologies from an “equal weight” rating to an “overweight” rating and set a $165.00 target price for the company in a research note on Monday, December 15th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Agilent Technologies in a report on Monday, December 29th. Hsbc Global Res upgraded Agilent Technologies to a “strong-buy” rating in a report on Tuesday, January 20th. Finally, Rothschild & Co Redburn started coverage on Agilent Technologies in a research report on Wednesday, October 8th. They issued a “buy” rating and a $165.00 price objective for the company. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $164.50.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.